MA32983B1 - Procede de preparation de composes optiquement actifs par hydrogenation par transfert - Google Patents

Procede de preparation de composes optiquement actifs par hydrogenation par transfert

Info

Publication number
MA32983B1
MA32983B1 MA34036A MA34036A MA32983B1 MA 32983 B1 MA32983 B1 MA 32983B1 MA 34036 A MA34036 A MA 34036A MA 34036 A MA34036 A MA 34036A MA 32983 B1 MA32983 B1 MA 32983B1
Authority
MA
Morocco
Prior art keywords
preparation
optically active
active compounds
hydrogenation
transport
Prior art date
Application number
MA34036A
Other languages
Arabic (ar)
English (en)
French (fr)
Inventor
Christian Mathes
Michael Foulkes
Martin Kesselgruber
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40344210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32983(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA32983B1 publication Critical patent/MA32983B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/002Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by transformation of a functional group, e.g. oxo, carboxyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/11Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA34036A 2008-12-24 2009-12-23 Procede de preparation de composes optiquement actifs par hydrogenation par transfert MA32983B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0823554.1A GB0823554D0 (en) 2008-12-24 2008-12-24 Process for the preparation of optically active compounds using transfer hydrogenation
PCT/EP2009/067821 WO2010072798A1 (en) 2008-12-24 2009-12-23 Process for the preparation of optically active compounds using transfer hydrogenation

Publications (1)

Publication Number Publication Date
MA32983B1 true MA32983B1 (fr) 2012-01-02

Family

ID=40344210

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34036A MA32983B1 (fr) 2008-12-24 2009-12-23 Procede de preparation de composes optiquement actifs par hydrogenation par transfert

Country Status (22)

Country Link
US (2) US8415508B2 (enExample)
EP (1) EP2382172A1 (enExample)
JP (1) JP2012513966A (enExample)
KR (1) KR20110098964A (enExample)
CN (1) CN102264672A (enExample)
AR (1) AR075496A1 (enExample)
AU (1) AU2009331493B2 (enExample)
BR (1) BRPI0923394A2 (enExample)
CA (1) CA2748349A1 (enExample)
CL (1) CL2011001563A1 (enExample)
CO (1) CO6382153A2 (enExample)
EC (1) ECSP11011221A (enExample)
GB (1) GB0823554D0 (enExample)
IL (1) IL213520A0 (enExample)
MA (1) MA32983B1 (enExample)
MX (1) MX2011006918A (enExample)
MY (1) MY151103A (enExample)
NZ (1) NZ593493A (enExample)
SG (1) SG172052A1 (enExample)
TN (1) TN2011000290A1 (enExample)
TW (1) TW201035028A (enExample)
WO (1) WO2010072798A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103193600B (zh) * 2012-01-07 2016-04-06 浙江九洲药物科技有限公司 卡巴拉汀中间体的制备方法
EP3009419A4 (en) * 2013-06-14 2017-01-18 Nissan Chemical Industries, Ltd. Production method for optically active alcohol compound
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种(r)-3-奎宁醇的制备方法
CN108752322A (zh) * 2018-09-12 2018-11-06 广州新民培林医药科技有限公司 一种新型Tepotinib衍生物和制备方法及其在抗肿瘤药物中的应用
CN109809967B (zh) * 2019-03-04 2022-03-18 陕西师范大学 一种合成手性醇的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
US4996235A (en) * 1987-11-25 1991-02-26 Eli Lilly And Company 3,4-diphenylbutanamines
JPH0899940A (ja) * 1994-09-30 1996-04-16 Kanegafuchi Chem Ind Co Ltd 光学活性な1−(3,4−ジメトキシフェニル)−2−アミノプロパンの製造法
GB9706321D0 (en) 1997-03-26 1997-05-14 Zeneca Ltd Catalytic hydrogenation
JP3938651B2 (ja) * 2000-04-13 2007-06-27 セントラル硝子株式会社 光学活性α−メチル−ビス−3、5−(トリフルオロメチル)ベンジルアミンの製造方法
KR20030062447A (ko) 2000-12-25 2003-07-25 아지노모토 가부시키가이샤 광학 활성 할로하이드린 화합물의 제조방법
DE602004017747D1 (de) * 2003-07-08 2008-12-24 Unilever Nv Verfahren zur herstellung einer kosmetisch aktiven verbindung
GB0329284D0 (en) 2003-12-18 2004-01-21 Avecia Ltd Process
US20070225528A1 (en) 2004-03-29 2007-09-27 Nagoya Industrial Science Research Center Process for Producing Optically Active Alcohol
US6939981B1 (en) * 2004-06-25 2005-09-06 Eastman Chemical Company Ruthenium complexes of phosphine-aminophosphine ligands
WO2006048720A1 (en) * 2004-11-08 2006-05-11 Emcure Pharmaceuticals Limited An efficient method for preparation of (s)-3-[(1-dimethyl amino)ethyl]-phenyl-n-ethyl-n-methyl-carbamate
WO2006137167A1 (ja) * 2005-06-20 2006-12-28 Kanto Kagaku Kabushiki Kaisha スルホナート触媒及びそれを利用したアルコール化合物の製法
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2007147897A1 (de) 2006-06-23 2007-12-27 Basf Se Verfahren zur herstellung von optisch aktiven 2-halogen-1-phenylethanol-derivaten und folgeprodukten davon
WO2009132443A1 (en) 2008-05-01 2009-11-05 Kanata Chemical Technologies Inc. Cationic transition-metal arene catalysts

Also Published As

Publication number Publication date
CO6382153A2 (es) 2012-02-15
SG172052A1 (en) 2011-07-28
CL2011001563A1 (es) 2012-01-13
US8415508B2 (en) 2013-04-09
ECSP11011221A (es) 2011-08-31
WO2010072798A1 (en) 2010-07-01
NZ593493A (en) 2013-03-28
JP2012513966A (ja) 2012-06-21
MY151103A (en) 2014-04-15
US8637713B2 (en) 2014-01-28
EP2382172A1 (en) 2011-11-02
US20100168229A1 (en) 2010-07-01
TN2011000290A1 (en) 2012-12-17
AU2009331493B2 (en) 2013-03-07
KR20110098964A (ko) 2011-09-02
BRPI0923394A2 (pt) 2016-01-12
AU2009331493A1 (en) 2011-07-07
MX2011006918A (es) 2011-07-29
US20130096337A1 (en) 2013-04-18
IL213520A0 (en) 2011-07-31
CN102264672A (zh) 2011-11-30
GB0823554D0 (en) 2009-01-28
CA2748349A1 (en) 2010-07-01
AR075496A1 (es) 2011-04-06
TW201035028A (en) 2010-10-01

Similar Documents

Publication Publication Date Title
CY1124873T1 (el) Διεργασια για την παρασκευη (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
MA32983B1 (fr) Procede de preparation de composes optiquement actifs par hydrogenation par transfert
IL196627A0 (en) Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-
MX393891B (es) Soporte de catalizador y catalizadores preparados a partir del mismo.
WO2003073998A3 (en) Local production and/or delivery of anti-cancer agents by stromal cell precursors
IL196626A0 (en) Preparation of 3-[(1r,2r)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
GEP20146053B (en) Compounds expanding hematopoietic stem cells
IN2012DN00739A (enExample)
MY145759A (en) Method for introducing into a reaction tube of a tube bundle reactor, a partial amount withdrawn from at least one production charge of annular-shaped shell catalysts k
EA201170911A1 (ru) Синтез стирилпиридинов, меченных радиоактивным изотопомf, из предшественников тозилата и их стабильные фармацевтические композиции
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
WO2009105749A3 (en) Preparation of a catalyst to attain low sulfur gasoline
MA34839B1 (fr) Dihydrofuranes condensés en tant que modulateurs de gpr119 pour le traitement du diabète, de l'obésité et de troubles apparentes
WO2010071852A3 (en) Oligonucleotide micelles
FR2984763B1 (fr) Procede de preparation d'un catalyseur utilisable en hydroconversion comprenant au moins une zeolithe nu-86
MY181657A (en) Catalyst for hydrogenolysis of polyhydric alcohol and method for producing 1,3-propanediol using catalyst for hydrogenolysis of polyhydric alcohol
DOP2009000255A (es) Extrudidos con enmascaramiento del sabor mejorado
EA201200095A1 (ru) Фармацевтические композиции и твердые формы
MY167591A (en) Method for producing hydroisomerization catalyst and method for producing lubricant base oil
MA32062B1 (fr) Sels de triazolium comme inhibiteurs de par1, leur production et leur utilisation comme médicaments
CL2008003895A1 (es) Compuestos derivados de 5-o-sustituido 3-n-fenil-1,3,4-oxadiazolonas, composicion farmaceutica, proceso de preparacion, y su uso para el tratamiento de un trastorno influenciado positivamente por la inhibicion de faah tal como trastornos alimenticios y patologias neurologicas y psiquiatricas, entre otras.
WO2009066321A3 (en) Process for optically active sulfoxide compounds
WO2006060692A3 (en) Supported group-4, group-5, and group-6 metal clusters, preparation of the material and use of the material as a catalyst
TH149233B (th) ตัวเร่งปฏิกิริยาโคบอลต์และโมลิบดีนัมบนตัวรองรับคาร์บอน
UA29551U (ru) Способ получения соединения с потенциальными физиологическими свойствами 7-(2'-бром-1',1'-дифтор-2'-хлоретил)-теофиллин